Yearly Publication Trends - Pharma

Year	Publication Count
2024	337
2023	1560
2022	1051
2021	797
2020	962
2019	279
2018	254
2017	156
2016	229
2015	147
2014	168

Relevant Publications

International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globe.

Issue Release: 2024

Genome and transcriptome exploration reveals receptor-like kinases as potential resistance gene analogs against bacterial blight in pomegranate.

Issue Release: 2024

Contraceptive technology is failing to meet the needs of people in the U.S. because of under-investment in new methods.

Issue Release: 2024

Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I-Bioequivalence of Acyclovir Topical Creams.

Issue Release: 2024

Causality, Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review.

Issue Release: 2024

Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review.

Issue Release: 2024

Advocating for Policy Change: Examples Emerging From a Medical-Legal Partnership in Primary Care.

Issue Release: 2024

Topical corticosteroid phobia among Danish pharmacy staff.

Issue Release: 2024

Pre-diagnostic plasma proteomics profile for hepatocellular carcinoma.

Issue Release: 2024

The use of proteins and peptides-based therapy in managing and preventing pathogenic viruses.

Issue Release: 2024

Safety and Efficacy of VIT against Wasp Venom in Ultra-Rush Protocols in Patients Older Than 60 Years.

Issue Release: 2024

Assessment of Extent and Quality of Pharmacoeconomic Studies in India Using Quality of Health Economic Studies Score: A Targeted Literature Review.

Issue Release: 2024

[Intravesical oxybutynin treatment for neurogenic detrusor overactivity : Efficacy and safety data from clinical practice with the first intravesical oxybutynin treatment authorized in Germany].

Issue Release: 2024

Sufficiency for PSS tracking gait disorders in multiple sclerosis: A managerial perspective.

Issue Release: 2024

Safety and efficacy of a feed additive consisting of DSM 34246 (Canobios-BL) for cats and dogs (ACEL pharma s.r.l.).

Issue Release: 2024

The HR revolution: Redefining performance paradigms in Pakistan\'s pharma landscape through moderating role of innovative climate.

Issue Release: 2024

Edge, Fog, and Cloud Against Disease: The Potential of High-Performance Cloud Computing for Pharma Drug Discovery.

Issue Release: 2024

Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.

Issue Release: 2024

Unveiling the potential anti-cancer activity of calycosin against multivarious cancers with molecular insights: A promising frontier in cancer research.

Issue Release: 2024

Canine Mucosal Artificial Colon: development of a new colonic in vitro model adapted to dog sizes.

Issue Release: 2024

What are the Implications for Pharma Companies?

What Are the Therapeutic Approaches to Mitigate Cellular Stress?

How Are Participants Protected?

What Should Be Included in Patient Education Materials?

What is Medication Management?

What is Transitional Care?

What is an Abbreviated New Drug Application (ANDA)?

What Role Does Regulatory Affairs Play?

What Roles Do Pharmacists Play in Pharma?

Why do Pharma Companies Use CROs?

Partnered Content Networks

Relevant Topics